{"protocolSection":{"identificationModule":{"nctId":"NCT04153942","orgStudyIdInfo":{"id":"H00018238"},"organization":{"fullName":"University of Massachusetts, Worcester","class":"OTHER"},"briefTitle":"Earlier Mobilization Post Acute Thrombolysis","officialTitle":"Earlier Mobilization Post Acute Thrombolysis","acronym":"EMPATHY-I"},"statusModule":{"statusVerifiedDate":"2023-10","overallStatus":"WITHDRAWN","whyStopped":"Study never started/initiated.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-08","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2024-07","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-10-21","studyFirstSubmitQcDate":"2019-11-04","studyFirstPostDateStruct":{"date":"2019-11-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-10-26","lastUpdatePostDateStruct":{"date":"2023-10-30","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Brian Silver","investigatorTitle":"Principal Investigator","investigatorAffiliation":"University of Massachusetts, Worcester"},"leadSponsor":{"name":"Brian Silver","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is a phase III trial trying to determine whether 12-hour bed rest following IV thrombolysis therapy (i.e. tPA) for ischemic stroke is non-inferior to 24-hour bed rest by measure of outcomes on the modified Rankin Scale (mRS) at 90 days post bed rest."},"conditionsModule":{"conditions":["Stroke","Stroke, Acute","Stroke, Ischemic"],"keywords":["Mobilization","Thrombolysis","Ischemia","Cerebrovascular Disorders","Brain Diseases","Recovery"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","maskingDescription":"Assessors blind to the subject's treatment/arm will do the evaluations at 90 days","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"12-Hour Bed Rest","type":"EXPERIMENTAL","description":"Subjects will be mobilized 12 hours after receiving IV thrombolysis therapy per usual care","interventionNames":["Behavioral: Mobilization"]},{"label":"24-Hour Bed Rest","type":"ACTIVE_COMPARATOR","description":"Subjects will be mobilized 24 hours after receiving IV thrombolysis therapy per usual care","interventionNames":["Behavioral: Mobilization"]}],"interventions":[{"type":"BEHAVIORAL","name":"Mobilization","description":"Any movement out of bed","armGroupLabels":["12-Hour Bed Rest","24-Hour Bed Rest"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"90 day mRS","description":"Proportion of patients with a modified Rankin Scale score (min 0, max 5 with 0 being best outcome) of 0-2 at 90 days","timeFrame":"90 days post bed rest"}],"secondaryOutcomes":[{"measure":"Pneumonia","description":"Determine whether rates of pneumonia are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.","timeFrame":"Duration of hospitalization stay, average 5 days"},{"measure":"Venous Thromboembolism","description":"Determine whether rates of VTE are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.","timeFrame":"Duration of hospitalization stay, average 5 days"},{"measure":"Neurological Worsening","description":"Determine whether rates of neurological worsening are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.","timeFrame":"Duration of hospitalization stay, average 5 days"},{"measure":"Readmission","description":"Determine whether rates of readmission are at least similar in the two arms.","timeFrame":"90 days post bed rest"},{"measure":"Length of Stay","description":"Determine whether hospital length of stay are at least similar in the two arms. This will ve measured in days.","timeFrame":"Duration of hospitalization stay, average 5 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 years or older\n* Received intravenous tPA for a clinical diagnosis of acute ischemic stroke\n* Patient and/or Legally Authorized Representative provide consent\n\nExclusion Criteria:\n\n* Venous thromboembolism present at symptom onset\n* Pneumonia present at symptom onset\n* STEMI at symptom onset\n* Positive troponins at symptom onset according to local values\n* Bone fracture at symptom onset\n* Treatment includes or anticipated to include thrombectomy\n* Intubation anticipated or occurred\n* Symptomatic intracranial hemorrhage (defined as increase in NIHSS by 4 points or more accompanied by PH2 hemorrhage on imaging) at the time of screening.\n* Pre-screening systolic blood pressure \\< 110 mmHg\n* Resting pulse oximetry \\< 92% (with or without supplemental oxygen)\n* Neurological worsening (defined as NIHSS increase of 4 points compared to initial score) prior to screening.\n* Baseline modified Rankin Scale score \\> 2\n* Known pregnancy\n* Patient not anticipated to survive 3 months\n* Patient not anticipated to follow-up at 3 months","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Brian Silver, MD","affiliation":"UMass Medical School","role":"PRINCIPAL_INVESTIGATOR"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}